
AbstractA 2‐year‐old boy with influenza B infection and rapidly worsening targetoid skin lesions with mucosal involvement was diagnosed with Stevens–Johnson syndrome (SJS) and treated with oseltamivir and intravenous immunoglobulin, with resolution of illness. Subsequent quadrivalent inactivated influenza vaccine was well tolerated. This case highlights the rarity of SJS in the setting of influenza B infection and addresses the safety of administering subsequent influenza vaccines to such individuals.
Male, Influenza B virus, Influenza Vaccines, Child, Preschool, Stevens-Johnson Syndrome, Influenza, Human, Humans, Immunoglobulins, Intravenous, Antiviral Agents, Skin
Male, Influenza B virus, Influenza Vaccines, Child, Preschool, Stevens-Johnson Syndrome, Influenza, Human, Humans, Immunoglobulins, Intravenous, Antiviral Agents, Skin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
